4-(6-Amino-1H-indol-3-yl)-5-iodo-pyrimidin-2-amine

ID: ALA1802409

PubChem CID: 53361566

Max Phase: Preclinical

Molecular Formula: C12H10IN5

Molecular Weight: 351.15

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc2c(-c3nc(N)ncc3I)c[nH]c2c1

Standard InChI:  InChI=1S/C12H10IN5/c13-9-5-17-12(15)18-11(9)8-4-16-10-3-6(14)1-2-7(8)10/h1-5,16H,14H2,(H2,15,17,18)

Standard InChI Key:  AIBYTTZDYVGOSH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   11.6114  -11.5211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6102  -12.3479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3246  -12.7606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3228  -11.1087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0376  -11.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0379  -12.3479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8278  -12.6044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3158  -11.9323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8273  -11.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0816  -10.4780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8894  -10.3075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1440   -9.5241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5919   -8.9106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7820   -9.0858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5310   -9.8690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2279   -8.4753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4406  -10.9205    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   10.8960  -12.7596    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  2  0
  9  5  1  0
  4  1  1  0
  5  6  1  0
 10 11  2  0
 11 12  1  0
  2  3  1  0
 12 13  2  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
  5  4  2  0
 14 16  1  0
  6  7  1  0
 11 17  1  0
  7  8  1  0
  2 18  1  0
M  END

Alternative Forms

Associated Targets(Human)

PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMR-32 (1082 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dyrk1a Dual specificity tyrosine-phosphorylation-regulated kinase 1A (1629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3-beta Glycogen synthase kinase-3 (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.15Molecular Weight (Monoisotopic): 350.9981AlogP: 2.39#Rotatable Bonds: 1
Polar Surface Area: 93.61Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.43CX LogP: 2.13CX LogD: 2.13
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.46Np Likeness Score: -0.43

References

1. Giraud F, Alves G, Debiton E, Nauton L, Théry V, Durieu E, Ferandin Y, Lozach O, Meijer L, Anizon F, Pereira E, Moreau P..  (2011)  Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.,  54  (13): [PMID:21623630] [10.1021/jm200464w]

Source